Home/Filings/4/0001104659-25-057809
4//SEC Filing

Duey Marc 4

Accession 0001104659-25-057809

CIK 0001781983other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:02 PM ET

Size

8.4 KB

Accession

0001104659-25-057809

Insider Transaction Report

Form 4
Period: 2025-06-05
Duey Marc
Director
Transactions
  • Award

    Stock Options (Right to Buy)

    2025-06-05+4,1854,185 total
    Exercise: $1.81Exp: 2035-06-05Common Stock (4,185 underlying)
  • Award

    Common Stock

    2025-06-05+1,045234,696 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    602
Footnotes (3)
  • [F1]These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
  • [F3]The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001925150

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:02 PM ET
Size
8.4 KB